(PharmaNewsWire.Com, July 19, 2017 ) The G8 Generics industry guide provides top-line qualitative and quantitative summary information including: market size (value and volume 2011-15, and forecast to 2020). The guide also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Features and benefits -Save time carrying out entry-level research by identifying the size, growth, and leading players in the G8 generics market -Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the G8 generics market -Leading company profiles reveal details of key generics market players' G8 operations and financial performance -Add weight to presentations and pitches by understanding the future growth prospects of the G8 generics market with five year forecasts -Compares data from the US, Canada, Germany, France, UK, Italy, Russia and Japan, alongside individual chapters on each country
Highlights The G8 countries contributed $142.9 billion in 2015 to the global generics industry, with a compound annual growth rate (CAGR) of 6% between 2011 and 2015. The G8 countries are expected to reach a value of $188.6 billion in 2020, with a CAGR of 5.7% over the 2015-20 period. Among the G8 nations, the US is the leading country in the generics industry, with market revenues of $94.0 billion in 2015. This was followed by Japan and Russia, with a value of $10.2 and $10.0 billion, respectively. The US is expected to lead the generics industry in the G8 nations with a value of $128.0 billion in 2016, followed by Russia and Japan with expected values of $15.9 and $11.9 billion, respectively.
Your key questions answered -What was the size of the G8 generics market by value in 2015? -What will be the size of the G8 generics market in 2020? -What factors are affecting the strength of competition in the G8 generics market? -How has the market performed over the last five years? -How large is the G8 generics market in relation to its regional counterparts?
Table of Contents INTRODUCTION What is this report about? Who is the target reader? How to use this report Definitions GROUP OF EIGHT (G8) GENERICS Industry Outlook GENERICS IN THE UNITED KINGDOM Market Overview Market Data Market Segmentation Market outlook Five forces analysis Leading companies Macroeconomic indicators GENERICS IN THE UNITED STATES Market Overview Market Data Market Segmentation Market outlook Five forces analysis Leading companies Macroeconomic indicators
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
